Analysis of IDH1 Mutation Spectrum from Non-Small-Cell Lung Cancer in East Asian Patients

被引:0
|
作者
Wang, L. [1 ]
Xu, C. [2 ]
Wang, W. [3 ]
Zhang, Q. [2 ]
Zhuang, W. [2 ]
Zhu, Y. [4 ]
Huang, Z. [2 ]
Chen, G. [5 ]
Fang, M. [3 ]
Lv, T. [6 ]
Song, Y. [6 ]
机构
[1] Baotou Canc Hosp, Baotou, Peoples R China
[2] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[3] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Rongjun Hosp, Thorac Dis Ctr, Jiaxing, Peoples R China
[5] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[6] Jinling Hosp, Nanjing, Jiangsu, Peoples R China
关键词
non-small-cell lung cancer; IDH1; mutation; prognosis;
D O I
10.1016/j.jtho.2019.08.2099
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP1.03-18
引用
收藏
页码:S960 / S960
页数:1
相关论文
共 50 条
  • [21] Detection of PAX5 Gene Mutations in Patients with East Asian Non-Small Cell Lung Cancer Patients
    Zhu, Y.
    Xu, C.
    Wang, W.
    Zhuang, W.
    Fang, M.
    Wang, G.
    Wang, Q.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S459 - S459
  • [22] Clinicopathologic Characteristics of Patients With PTPN11 Mutations in East Asian Non-Small Cell Lung Cancer Patients
    Lou, F.
    Xu, C.
    Wang, W.
    Wang, D.
    Zhu, Y.
    Zhuang, W.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S528 - S529
  • [23] PRKDC Mutations Recurrently Found in Non-Small Cell Lung Cancer in East Asian Patients
    Lan, F.
    Wang, W.
    Xu, C.
    Wang, D.
    Zhu, Y.
    Zhuang, W.
    Fang, M.
    Li, W.
    Wang, G.
    Wang, Q.
    Song, Y.
    Lu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1216 - S1216
  • [24] Different Types of CDK4 Mutations in East Asian Non-Small Cell Lung Cancer Patients
    Xu, C.
    Wang, W.
    Wang, D.
    Zhu, Y.
    Zhuang, W.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S532 - S532
  • [25] Association Between Molecular Spectrum of EZH2 Variants and Prognosis in Patients with Non-Small-Cell Lung Cancer in Chinese Patients
    Wang, H.
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Huang, Z.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S954 - S955
  • [26] Prevalence and Clinicopathological Characteristics of ARID1A Mutations in East Asian Patients With Non-Small Cell Lung Cancer
    Xu, C.
    Wang, W.
    Wang, D.
    Zhu, Y.
    Zhuang, W.
    Fang, M.
    Wang, G.
    Wang, Q.
    Song, Y.
    Lu, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1214 - S1215
  • [27] The Association Between MAP2K1 Mutation Class and Clinical Features in MAP2K1-Mutant East Asian Non-Small Cell Lung Cancer Patients
    Wang, W.
    Xu, C.
    Wang, D.
    Zhu, Y.
    Zhuang, W.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S564 - S564
  • [28] Clinicopathologic characteristics and outcomes of Chinese patients with non-small-cell lung cancer and BRAF mutation
    Ding, Xi
    Zhang, Zengli
    Jiang, Tao
    Li, Xuefei
    Zhao, Chao
    Su, Bo
    Zhou, Caicun
    CANCER MEDICINE, 2017, 6 (03): : 555 - 562
  • [29] SURVIVAL ANALYSIS OF UNTREATED PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    VRDOLJAK, E
    MISE, K
    SAPUNAR, D
    ROZGA, A
    MARUSIC, M
    CHEST, 1994, 106 (06) : 1797 - 1800
  • [30] Exploration of lung mycobiome in the patients with non-small-cell lung cancer
    Yiming Zhao
    Junqi Yi
    Juanjuan Xiang
    Wei Jia
    Anqi Chen
    Liyu Chen
    Leliang Zheng
    Wen Zhou
    Minghua Wu
    Zheng Yu
    Jingqun Tang
    BMC Microbiology, 23